Femasys is trading 6.40% up at $2.69, following a generally risk-on overnight backdrop.

  • No new company-specific announcement dated September 21–22, 2026, was identified.
  • The latest notable update was the September 15 Minnesota Women’s Care adoption of FemaSeed and FemVue.
  • The move appears sentiment-driven rather than tied to fresh company news.